August 27, 2025

Real Estate

Technology

MannKind expands pipeline with $350M acquisition

MannKind CEO Michael Castagna. (file photo) Westlake Village-based MannKind Corporation is expanding its pipeline by acquiring scPharmaceuticals, a Massachusetts-based biotech company that specializes in cardiorenal medicine, for $360 million, or $5.35 per share. Announced before the markets opened Aug. 25, MannKind shares ticked up about 1% in pre-market trading. Shares ultimately settled at $3.90 on Aug. 25, about 3.1% down. Shares of scPharmaceuticals closed at $5.52 with a 13% gain. Read More >

Agribusiness

Newsmakers

Sponsored Content
Dr. James Cruz

Gold Coast Health Plan

Stephanie Hastings

Brownstein Hyatt Farber Schreck

Marlen Torres

Gold Coast Health Plan

ADVERTISING

Reach our audience with your message

Pacific Coast Business Times provides marketers with access to an affluent, educated business community of decision-makers via multimedia formats. Whichever media format or combination of media you choose, the Business Times helps you reach your marketing and sales goals.

Connect with our audience

94%

Answered the Business Times had influenced their buying decisions.

92%

Read the Pacific Coast Business Times for business news.

78%

Have obtained a four-year college degree.